Cumberland Buys Rights to Possible Kidney Failure Treatment
Links shared publicly online about this topic.
- 352total visits
Cumberland Buys Rights to Possible Kidney Failure Treatment
Cumberland Pharmaceuticals Inc. announced April 19 that it has acquired the rights from Vanderbilt University to a molecule called ifetroban, and the company plans to test it as a potential in-hospital treatment for a condition that involves progressive kidney failure
View full resource at renalbusiness.com
Tags: Kidney Health, Urinary System, Kidney Disease, Kidney Failure, Pharma
Most Recently Shared on April 20, 2011 at 12:56 am By:
RT @renal_business: Cumberland Buys Rights to Possible Kidney Failure Treatment: Cumberland Pharmaceutical http://bit.ly/hmZqMO
Advertisement
